Talk to the Veterans Crisis Line now
An official website of the United States government
IAA 07-071
Presence and Correlates of Racial Disparities in Pain Management
Diana J. Burgess, PhD Minneapolis VA Health Care System, Minneapolis, MN Minneapolis, MN Funding Period: September 2009 - August 2011 |
|
BACKGROUND/RATIONALE:
Prior research has identified racial disparities in pain management across a variety of disease types and treatment settings. These studies have consistently shown that Whites receive better pain management than other races. A pilot study we conducted in VA provided preliminary evidence of similar disparities, pointing to a need to further study and understand how racial disparities in pain management in VA can be eliminated. Recent evidence suggests that racial disparities may be less likely or smaller in magnitude in facilities with greater QI initiatives and resources that support high quality pain management. OBJECTIVE(S): The objectives of this study were to assess the extent to which racial disparities in pain management (screening, treatment, and outcomes) exist across VHA facilities and whether racial disparities are reduced in facilities with greater QI initiatives and resources that support high quality pain management. METHODS: To obtain a representative sample of the VA primary care population for which we could well identify race, we used the sampling frame for the 2007 Survey of Healthcare Experiences of Patients (SHEP) ambulatory care module. A) To examine racial disparities in pain screening (whether a pain score was recorded at the SHEP sampling visit), we utilized a base cohort of 27,683 Black and 233,765 White veterans from the SHEP. B) To examine disparities in pain treatment (type and duration of pain medication prescribed), we restricted attention to patients diagnosed with chronic pain (chronic low back, neck, or joint pain, or rheumatism) in the year prior to the SHEP sampling visit. C) To examine whether racial disparities exist in pain outcomes (perceived treatment effectiveness and functional interference due to pain reported on the SHEP), we restricted our sample to patients diagnosed with chronic pain in the prior year who reported they were treated for chronic pain in the VA in the past year. Data on pain management QI initiatives and resources were obtained from the 2007 VHA Clinical Practice Organizational Survey Primary Care Directors Module (CPOS). Key variables included: 1) tools promoting adherence to chronic pain management (e.g., computerized reminders; performance profiling and provider feedback, provider education); 2) chronic pain management resources in primary care; and 3) average wait for chronic pain patients to access specialty assessment and medication management, specialty interventional pain management, and physical therapy. In all analyses, we accounted for clustering by site and whether the patient was a new or established primary care patient as the SHEP sample is selected by facility and type of patient encounter. FINDINGS/RESULTS: A) Black patients were less likely than their White counterparts to be screened for pain (OR: 0.79 p < .0001) with estimated screening rates of 78% and 82% for Black and White established primary care patients at a typical VA facility, respectively. Further adjustment for demographic, medical and psychological comorbidity, active prescription of pain medication, outpatient utilization, and facility characteristics yielded an odds ratio of 0.86, (85% versus 87%, p < .05). Additional analyses revealed this reduction was explained by higher rates of outpatient visits in the two years prior to the index visit among Black patients, which was associated with lower rates of screening at the index visit. B) Among chronic pain patients treated for pain in the past year, Blacks were more likely to be prescribed an opioid (OR=1.28, p<.0001; whites 19.96%, blacks 24.18%). However, when controlling for all covariates, Whites were more likely to be prescribed an opioid (OR=.87, p<.0001; whites: 15.20%, blacks: 13.47%). This reversal in the relationship between race and opioid prescriptions was primarily due to higher average pain scores and younger age among African Americans, both of which were associated with greater opioid prescription rates. C) Among VA chronic pain patients treated for pain in the VA in the past year, who responded to the SHEP, Blacks were significantly less likely than their White counterparts to perceive their pain treatment as good, very good, or excellent (55% versus 60%, OR: 0.83, p = .0002). Adjusting for demographic, medical and psychological comorbidity, healthcare utilization, and facility characteristics reduced the estimated odds ratio to .91(p=.00). Additional analyses revealed that this reduction was explained primarily by the fact that Black patients were younger and were more likely to get non-opioids as opposed to opioids, both of which were associated with lower satisfaction with pain treatment. Similarly, among this sample of VA chronic patient patients who responded to the SHEP, Blacks were significantly more likely than their Whites to report experiencing functional interference due to pain moderately, quite a bit, or extremely over the past 4 weeks (69% versus 63%, OR: = 1.34 p < . 0001.) Adjusting for demographic, medical and psychological comorbidity, healthcare utilization, and facility characteristics reduced the estimated odds ratio to 1.06 (p =.16). This reduction in odds ratio was explained by the fact that Black patients were younger and were more likely to be treated with non-opioids as opposed to opioids, both of which were associated with greater functional interference. D) We did not find support for our hypothesis that racial disparities in pain management would be reduced in facilities with greater QI initiatives and resources that support high quality pain management. Indeed, there was no consistent association between organizational factors that were expected to be related to high quality pain management and racial disparities in pain screening, treatment, perceived effectiveness of treatment, and functional interference due to pain. Moreover, we found little evidence that broader facility characteristics (such as size, region, whether facility was a VAMC or CBOC) moderated the association between race and pain management. IMPACT: This project identified racial disparities in pain management in VA. These disparities were not associated with the facility-level processes and structures that support high quality pain management measured as part of CPOS. Future research, potentially looking at other facility-level measures, is needed to understand how to reduce these disparities, particularly given the higher level of pain reported by Black Veterans with chronic pain. External Links for this ProjectDimensions for VA Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects. Learn more about Dimensions for VA. VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address. Search Dimensions for this project PUBLICATIONS:Journal Articles
DRA:
Health Systems, Other Conditions
DRE: Etiology Keywords: Disparities, Organizational issues, Pain MeSH Terms: none |
